Physician profile
Rodney Slone
NPI 1194890681
$1,902.88
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,809 · 2020: $93.95.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $371.47 | 2019 | |
| Janssen Pharmaceuticals, INC | $237.24 | 2019 | |
| Pfizer INC. | $211.97 | 2019-2020 | |
| Amgen INC. | $196.95 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $195.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.67 | 2019-2020 | |
| Lilly USA, LLC | $130.10 | 2019 | |
| Merck Sharp & Dohme LLC | $120.12 | 2019 | |
| Allergan, INC. | $59.21 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $57.32 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.99 | 2019-2020 | |
| Amarin Pharma, INC. | $35.93 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.35 | 2019 | |
| Glaxosmithkline, LLC. | $27.27 | 2019 | |
| Novo Nordisk INC | $24.23 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $12.07 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Slone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.